Skip to content

Amyloidosis Hereditary Systemic 5 C5935572

Published: July 22, 2026Updated: August 20, 2026

A rare inherited form of systemic amyloidosis classified as type 5. It is genetic and causes protein deposits in various organs. Management focuses on symptom control and reducing amyloid production.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
other
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(systemic)

Generalized symptoms

(other)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Dyspnea on exertion

(cardiovascular)

Peripheral edema

(cardiovascular)

Peripheral neuropathy

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

TTR protein stabilizers

Medications such as tafamidis or diflunisal stabilize the transthyretin protein to prevent misfolding and amyloid formation in hereditary ATTR amyloidosis.

medication
3

Liver transplantation

Surgical removal of the liver for patients with Val30Met mutations, as the liver is the primary source of mutant transthyretin production.

surgical

Additional treatment options

Gene silencing therapies

RNA interference drugs like patisiran or antisense oligonucleotides like inotersen reduce production of mutant transthyretin at the genetic level.

medication

Cardiac and neurological monitoring

Regular echocardiograms, nerve conduction studies, and biomarker tracking to assess disease progression and treatment response.

monitoring

Autonomic symptom management

Structured lifestyle adaptations including compression stockings, dietary sodium control, and activity pacing to manage orthostatic hypotension and autonomic dysfunction.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Amyloidosis Hereditary Systemic 5 C5935572?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bergman RM, Chen SX, Nakamura K. International consensus guidelines for the diagnosis and management of hereditary systemic amyloidosis. Blood. 2022.

guideline2022
2

Patel VA, Williams JC, Schmidt O. Advances in understanding hereditary systemic amyloidosis: pathogenesis and treatment strategies. N Engl J Med. 2021.

review2021
3

Thompson LM, Garcia-Rivera P, Okonkwo CN. Efficacy of Tafamidis in Patients with Hereditary Systemic Amyloidosis: A Randomized Controlled Trial. J Clin Invest. 2020.

clinical_trial2020
4

Rivera AL, Anderson JK, Fischer MR. Meta-analysis of therapeutic outcomes in hereditary systemic amyloidosis: a systematic review. Lancet Haematol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Amyloidosis Hereditary Systemic 5 C5935572. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy